RE:RE:RE:RE:SESN...fredgoodwinson wrote: Theralase will be trying to get into Phase II asap but since we now require another ITA (a modification for the real-time monitoring of PLIM/FLIM?) the Company could help itself a lot just by releasing the information that this has actually been applied for - if it has.
They thought it worth announcing the last ITA application and just to tell us this time that ITA and REB approval is anticipated ' in due course' doesn`t cut it.
The fastest that we have ever been granted an ITA was 84 days` for the last application and that was lightning-quick compared to previous experience.
If the ITA has not yet been applied for we can pretty much forget a Phase II start in the early New Year.
Fredgoodwinson, you're making a good case for investors waiting until the uncertainty clears up. Shareholders can only hope that information will be released Monday along with the status of the PP. For those that don't think having a new CEO matters then consider if it's worth you constantly not knowing what is going on. Who is running TLT, the interim CEO who is more a science guy, the CFO or is it our old friend the business development guy? Does it even matter when nothing ever seems to change in the way this company informs its shareholders?